​

The Division of Medical Oncology (DMO) is a clinical department in NCCS which is greatly engaged in clinical and translational cancer research. In line with the clinical specialties of the DMO investigators, our research mainly focuses on the following cancer types:
• Women’s cancers
• Lymphoma
• Gastrointestinal cancers
• Lung, head and neck cancers
• Urologic cancers
• Sarcoma and other rare malignancy

We also have special focus on cancer genetics, early phase clinical trials as well as health services research.

We have strong industrial collaborations with both local and overseas bio-Pharma /biotechnology companies. Also we work closely with various local and overseas research institutions and universities. Several of our investigators hold joint positions in A*STAR research institutions (GIS and IMCB) which provide great opportunities for the investigators and the research teams to bring the basic and clinical cancer research together.

The DMO Research Department, home to 60 clinician scientists/investigators and translational PI, is supported by 2 research managers, 1 database manager, 3 data management coordinators, 1 bioinformatics specialist, 4 project managers, 11 research fellows, 5 research associates, 11 research officers, 3 research technicians, 28 research coordinators, 11 associate research coordinators, and a strong research administration team.

Research plays a crucial role in improving the quality of clinical care. We aim to establish a conducive and sustainable research environment in the division, to conduct excellent research to improve cancer treatment, and nurture young clinician researchers to be the next generation academic oncologists.